Integrating pharmacokinetic-pharmacodynamic modeling in preclinical assessment of mutant selective EGFR covalent tyrosine kinase inhibitor EGF816
- Resource Type
- Source
- Drug Metabolism and Pharmacokinetics. 34:S68
- Subject
Pharmacology Pharmacokinetic pharmacodynamic Chemistry Covalent bond medicine.drug_class Mutant medicine Pharmaceutical Science Pharmacology (medical) Tyrosine-kinase inhibitor - Language
- ISSN
- 1347-4367